InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Floyd Robert Michael, Chief Executive Officer. Officer active across 1 companies, notably Processa Pharmaceuticals, Inc.. In total, 5 filings have been recorded. Total volume traded: €24k. The latest transaction was filed on 31 March 2022 — Don. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
07,000 shares0
Common Stock
SEC:0001567619-22-007993:0·
12,500 shares
Common Stock
SEC:0001567619-21-018171·
12,500 shares
Common Stock
SEC:0001567619-21-018171:0·
€11,7772,000 shares@ €5.88870.18% mcap100.0% of flow
Common Stock
SEC:0001567619-21-012496·
Ideal exit: 19 Mar 2022 (T+270)
€11,7772,000 shares@ €5.88870.18% mcap50.0% of flow
Common Stock
SEC:0001567619-21-012496:0·
Ideal exit: 19 Mar 2022 (T+270)
5 of 5 declarations
About Floyd Robert Michael
Robert Michael Floyd is the Chief Operating Officer at Processa Pharmaceuticals, Inc. He oversees the daily operations of the company, ensuring efficiency and compliance of processes. His role is essential in supporting the operational strategy and growth of Processa Pharmaceuticals, Inc.
